Showing results (41-50 of 124) with videos related to
Sort By:
Pageof 13
Rheumatology and Therapy|June 28, 2018
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis PopulationStephen Hall, Peter Nash, Maureen Rischmueller, et al.Rheumatology and Therapy|December 28, 2021
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial SpondyloarthritisSteven L Truong, Tim McEwan, Paul Bird, et al.The Journal of Rheumatology|July 3, 2015
Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational StudyGeoffrey Littlejohn, Lynden Roberts, Paul Bird, et al.International Journal of Rheumatic Diseases|March 29, 2014
Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)Philip C Robinson, Paul Bird, Irwin Lim, et al.Rheumatology (Oxford, England)|April 11, 2018
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trialAlvin F Wells, Christopher J Edwards, Alan J Kivitz, et al.Medicine|December 2, 2014
How well do patients understand written instructions?: health literacy assessment in rural and urban rheumatology outpatientsPeter K K Wong, Laura Christie, Jenny Johnston, et al.The Lancet. Public Health|August 29, 2022
Prevention and treatment of infectious diseases in migrants in Europe in the era of universal health coverageRebecca F Baggaley, Dominik Zenner, Paul Bird, et al.BMJ Quality & Safety|September 29, 2021
Examining organisational responses to performance-based financial incentive systems: a case study using NHS staff influenza vaccination rates from 2012/2013 to 2019/2020Adiba Liaqat, Suzy Gallier, Katharine Reeves, et al.International Journal of Rheumatology|June 21, 2017
The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology PracticeLynden Roberts, Kathleen Tymms, Julien de Jager, et al.BMC Infectious Diseases|March 3, 2026
Prevalence and risk factors for key infectious diseases amongst migrants to the UK: a systematic reviewRebecca F Baggaley, Carys M Hooper, Luisa Silva, et al.Pageof 13